- Home
- THRD vs ASA Comparison
THRD vs ASA Comparison
Compare THRD & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- ASA
- Stock Information
- Founded
- THRD 2019
- ASA 1958
- Country
- THRD United States
- ASA United States
- Employees
- THRD N/A
- ASA N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- ASA Precious Metals
- Sector
- THRD Health Care
- ASA Industrials
- Exchange
- THRD Nasdaq
- ASA Nasdaq
- Market Cap
- THRD 512.9M
- ASA 428.1M
- IPO Year
- THRD 2022
- ASA N/A
- Fundamental
- Price
- THRD $13.93
- ASA $21.71
- Analyst Decision
- THRD Strong Buy
- ASA
- Analyst Count
- THRD 3
- ASA 0
- Target Price
- THRD $20.33
- ASA N/A
- AVG Volume (30 Days)
- THRD 184.1K
- ASA 48.2K
- Earning Date
- THRD 11-07-2024
- ASA 11-19-2024
- Dividend Yield
- THRD N/A
- ASA 0.19%
- EPS Growth
- THRD N/A
- ASA 302.95
- EPS
- THRD N/A
- ASA 4.56
- Revenue
- THRD N/A
- ASA $1,993,559.00
- Revenue This Year
- THRD N/A
- ASA N/A
- Revenue Next Year
- THRD N/A
- ASA N/A
- P/E Ratio
- THRD N/A
- ASA $4.66
- Revenue Growth
- THRD N/A
- ASA N/A
- 52 Week Low
- THRD $5.82
- ASA $12.80
- 52 Week High
- THRD $16.94
- ASA $22.78
- Technical
- Relative Strength Index (RSI)
- THRD 54.76
- ASA 52.08
- Support Level
- THRD $11.69
- ASA $21.02
- Resistance Level
- THRD $14.64
- ASA $22.50
- Average True Range (ATR)
- THRD 0.99
- ASA 0.34
- MACD
- THRD -0.04
- ASA -0.14
- Stochastic Oscillator
- THRD 67.67
- ASA 38.92
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation primarily through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.